Analysed QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) News Sources
Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis
30-03-2026
yahoo.com
Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis
01-04-2026
yahoo.com
Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied
02-04-2026
yahoo.com
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant
22-04-2026
yahoo.com
Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026
07-05-2026
yahoo.com
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital
18-05-2026
yahoo.com
Quantum BioPharma Shares Climb as Multiple Sclerosis Imaging Study Advances (QNTM)
18-05-2026
advfn.com
Quantum BioPharma Reaches Halfway Point in Patient Enrollment in Imaging Study With MGH
19-05-2026
yahoo.com
What is the current price of QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ)?
The current price of QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) is $6.86.
QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) absolute price change since previous trading day?
The absolute price change of QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) since the previous trading day is $-0.16.
QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) percentage price change since previous trading day?
The percentage price change of QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) since the previous trading day is -2.2792%.
What is the most recent average sentiment score for QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ)?
The most recent average sentiment score for QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ)?
The most recent sentiment for QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) is .
SEC-8K** Filing Available For QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.